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Abstract
Women with bacterial vaginosis (BV), an imbalance of the vaginal microbiome, are more
likely to be colonized by potential pathogens such as Fusobacterium nucleatum, a bacterium
linked with intrauterine infection and preterm birth. However, the conditions and mechanisms
supporting pathogen colonization during vaginal dysbiosis remain obscure. We demonstrate
that sialidase activity, a diagnostic feature of BV, promoted F. nucleatum foraging and growth
on mammalian sialoglycans, a nutrient resource that was otherwise inaccessible because of
the lack of endogenous F. nucleatum sialidase. In mice with sialidase-producing vaginal
microbiotas, mutant F. nucleatum unable to consume sialic acids was impaired in vaginal col-
onization. These experiments in mice also led to the discovery that F. nucleatum may also
“give back” to the community by reinforcing sialidase activity, a biochemical feature of human
dysbiosis. Using human vaginal bacterial communities, we show that F. nucleatum supported
robust outgrowth of Gardnerella vaginalis, a major sialidase producer and one of the most
abundant organisms in BV. These results illustrate that mutually beneficial relationships
between vaginal bacteria support pathogen colonization and may help maintain features of
dysbiosis. These findings challenge the simplistic dogma that the mere absence of “healthy”
lactobacilli is the sole mechanism that creates a permissive environment for pathogens dur-
ing vaginal dysbiosis. Given the ubiquity of F. nucleatum in the human mouth, these studies
also suggest a possible mechanism underlying links between vaginal dysbiosis and oral sex.
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Introduction
Bacterial vaginosis (BV) is an imbalance or dysbiosis of the vaginal microbiome that affects
approximately 29% of US women [1]. BV is characterized by low levels of “beneficial” lactoba-
cilli and overgrowth of bacteria from diverse taxonomic groups [2–4]. Women with BV are at
higher risks of various adverse health outcomes and infection-related complications and are
more likely to be vaginally colonized by the potentially pathogenic bacterial taxa that cause
these infections [5–12]. For example, BV-positive women and those with amniotic fluid infec-
tions and preterm labor are more likely to be vaginally colonized by Fusobacterium nucleatum
[3,9,13]. Unfortunately, mechanisms of pathogen colonization within the BV niche are poorly
understood. It is widely held that a healthy microbiome thwarts the entry of potentially patho-
genic members into the community (referred to as “colonization resistance”) and that the loss
of this “colonization resistance” plays a vital role in the development of vaginal dysbiosis [14].
We suggest that bacterial communities of the dysbiotic vaginal niche also rely on mutually sup-
porting metabolic interactions to stabilize communities, as described in other microbial eco-
systems [15–19].
One biochemical characteristic of BV is the presence of sialidase activity in vaginal fluids
[20–22]. Sialidase activity may contribute to complications of BV. For example, high sialidase
activity in vaginal fluids is associated with increased risk of preterm birth [21,23]. Sialidases
play diverse roles in bacterial–host interactions, coinfection, and dysbiosis in oral, gastrointes-
tinal, and airway systems [17,18,24–30]. We hypothesize that bacterial sialidases also play
important roles in pathogen colonization and dysbiosis in the vagina. Bacterial sialidases liber-
ate mucosal carbohydrates called sialic acids from glycan chains of secreted mucus compo-
nents and cell surface glycoproteins. In BV, vaginal mucus secretions have higher levels of
free/liberated sialic acid [31–33]. Gardnerella vaginalis, an abundant species in BV, produces
sialidases to release and forage sialic acids from glycan chains of sialoglycoproteins [31,34].
However, not all bacteria that catabolize sialic acids express sialidase [35,36]. Here, we examine
the idea that in the sialidase-positive vaginal niche, the ability to utilize free sialic acid may pro-
vide fitness benefits to sialidase-negative potential pathogens, facilitating their growth and
persistence.
F. nucleatum is a gram-negative spindle-shaped obligate anaerobe that is ubiquitous in the
human mouth but also one of the most commonly isolated microorganisms from amniotic
fluid of women in preterm labor [37–39]. Although the prevailing view is that F. nucleatum
reaches the amniotic fluid through an oral–hematogenous route [40], vaginal colonization
with F. nucleatum is also a risk factor for amniotic fluid infection and preterm birth [13]. F.
nucleatum is not known to express sialidase of its own [41], but it commonly resides among
sialidase-producing bacteria in the mouth, gut, and vagina [42–46]. Some F. nucleatum strains
also encode putative sialic acid catabolic pathways, although functional characterization of the
corresponding gene products is still limited [47–51]. We hypothesized that F. nucleatum may
derive nutritional benefit from host sialoglycans when exogenous sialidases produced by other
bacteria are present. Here, we use in vitro approaches and a mouse model to show that F.
nucleatum cannot obtain sialic acid from intact glycoconjugates, in which sialic acid is bound
to underlying glycans, but can nevertheless benefit from sialic acid catabolism when colonizing
a sialidase-positive vaginal niche. Unexpectedly, our models also led to the discovery that F.
nucleatum does not act in a simple one-way relationship with sialidase-producing bacteria, but
rather engages in a mutually beneficial relationship. In fact, the data demonstrate that F. nucle-
atum exposure to vaginal communities may encourage features of dysbiosis (increased siali-
dase activity and G. vaginalis abundance) in susceptible vaginal communities. These results
may help explain why women with BV are at increased risk of vaginal colonization by some
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pathogens such as F. nucleatum. Additionally, our data suggest that mutual reinforcement
between bacterial species, made possible in part through metabolite cross-feeding, promotes
pathogen colonization and vaginal dysbiosis.
Results
Subsets of F. nucleatum consume free sialic acid
An organism’s ability to colonize an already-occupied niche depends on its ability to access
nutrients for growth. Some mucosal bacteria forage on host sialic acids by importing them
from the extracellular environment through a sialic acid transporter and then converting them
to N-acetyl-mannosamine and pyruvate using a sialate lyase (N-acetylneuraminate lyase,
NanA) [52–54]. Recent studies suggest that F. nucleatum may encode these functionalities
[48–50]. Here, we used an amino acid sequence of the well-characterized Escherichia coli
NanA (MG1655, GenBank: AAC76257.1) to search for homologous proteins in F. nucleatum.
A bioinformatic analysis of 28 F. nucleatum proteomes spanning several subspecies identified
NanA homologs in most members of the subspecies nucleatum and vincentii and some strains
of animalis, but not in the subspecies polymorphum (S1 Fig). Functional analyses of free sialic
acid foraging among a collection of F. nucleatum strains were consistent with these genomic
predictions. Members of the subspecies nucleatum and vincentii were competent foragers of
free sialic acid, but the tested strains of animalis and polymorphum were not (Fig 1A). Analyses
of other members of the order Fusobacteriales suggested that some species in addition to F.
nucleatum (for example, F. mortiferum) may catabolize sialic acids, but sialic acid consumption
is not ubiquitous.
To test whether the nanA identified from F. nucleatum strain American Type Culture Col-
lection (ATCC) 23726 encodes a functional sialic acid lyase, the gene was cloned into an E. coli
expression plasmid and transformed into a ΔnanA deletion mutant of E. coli [36] (S1 Table).
On its own, E. coli ΔnanA (containing an empty vector) was unable to grow on sialic acid as a
sole carbon source (Fig 1B). However, growth was restored by complementation with plasmids
containing either E. coli nanA or F. nucleatum nanA. Sialate lyase activity was also assayed in
clarified lysates by measuring the disappearance of N-acetylneuraminic acid (Neu5Ac) over
time. The amount of remaining sialic acid was measured by fluorescent derivatization and
high-performance liquid chromatography (HPLC) analysis by comparison to synthetic
Neu5Ac standards processed in parallel. As expected, the E. coli ΔnanA strain containing
empty vector did not have sialic acid lyase activity (Fig 1C). However, in reactions with lysates
from the complemented strains, >80% of the sialic acid was depleted within 30 min (Fig 1C).
These results demonstrate that F. nucleatum NanA (GenBank: EFG95907.1) functions as a sia-
late lyase.
In F. nucleatum (ATCC23726), the nanA gene is found downstream of a putative sialic acid
transporter (siaT) in a gene cluster encoding other enzymes with predicted roles in carbohy-
drate metabolism (S2 Table). To further assess the importance of F. nucleatum sialic acid
catabolism, a minimal suicide vector targeting the siaT gene was designed for insertional
mutagenesis in a streptomycin-resistant (SmR) isolate of F. nucleatum ATCC23726 (Fig 2A).
This plasmid was used to generate a strain in which siaT was disrupted (OsiaT; Fig 2B). Here-
after, the F. nucleatum wild type (WT) and OsiaT mutant are referred to as “WT” and “OsiaT.”
Analysis of the transcripts by reverse transcription–quantitative PCR (RT-qPCR) throughout
this gene cluster in the OsiaT mutant showed that the transcription of genes upstream of siaT
were unaffected by the insertion (Fig 2C). As expected, there was an approximately 5-fold
reduction in transcript of 3 genes downstream of the mutation site that are involved in sialic
acid catabolism. Consistent with these findings, OsiaT was unable to forage on free sialic acid
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(Neu5Ac) (Fig 2D), even though both strains grew similarly in the nutrient-rich media used
for this experiment (S2 Fig). F. nucleatum is a fastidious anaerobe, and single-carbon–source
experiments are not feasible as an experimental strategy. Therefore, we developed a nutrient-
limited media containing some of the base components of Columbia media, as described in
the Methods. Reducing the nutrient content of the growth media made it possible to investi-
gate the impact of sialic acid foraging on the growth of F. nucleatum when resources are lim-
ited. Experiments were performed in nutrient-limited media with or without added
carbohydrate sources. Briefly, WT and OsiaT were inoculated into a nutrient-limited medium,
either with no added carbohydrate or with added monosaccharides—glucose or free sialic acid
(Neu5Ac). Both WT and OsiaT grew poorly in low-carbohydrate medium, reaching a plateau
at an optical density (OD)600 of approximately 0.25, and both grew well in medium containing
Fig 1. Analysis of sialic acid utilization by Fusobacteria and functional evidence of F. nucleatum-encoded sialate
lyase (nanA). (A) Amount of sialic acid remaining in the growth medium 24–48 h postinoculation of different
Fusobacteria (as indicated) or uninoculated media control. Subspecies of F. nucleatum are indicated in blue text. All
Fusobacteria were grown in supplemented Columbia medium with free sialic acid added (Neu5Ac, 100 μM)—medium
that was also used as uninoculated control. E. coli (MG1655), a known sialic acid consumer, cultured in LB medium
with added free sialic acid (Neu5Ac, 100 μM) was included as a positive control. Error bars shown are standard
deviation of the mean from 3 independent experiments. (B–C) E. coli MG1655 ΔnanA was complemented with empty
vector, E. coli nanA or putative nanA from F. nucleatum ATCC23726 (GenBank accession EFG95907). Data shown are
representative of 3 independent experiments. (B) Growth was assessed in minimal media with sialic acid by measuring
absorbance at 600 nm. (C) Lysates of the E. coli nanA mutant with empty vector or the complemented strain were
incubated with sialic acid (Neu5Ac), and its disappearance was monitored over time by fluorescent derivatization
(with DMB) followed by HPLC. The underlying numerical data for this figure can be found in S1 Data. Strain names:
FQG51A, JM6, JM4, JMH52, JMP2A, JMSY1, SYJL4. Description of bacterial strains can be found in S1 Table. ATCC,
American Type Culture Collection; DMB, 1,2-diamino-4,5-methylenedioxybenzene; E.c., E. coli; F.n., F. nucleatum;
HPLC, high-performance liquid chromatography; LB, lysogeny broth; nanA, N-acetylneuraminate lyase; Neu5Ac, N-
acetylneuraminic acid; OD, optical density.
https://doi.org/10.1371/journal.pbio.3000788.g001
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Fig 2. Insertional mutagenesis to disrupt sialic acid catabolic pathway in F.n. ATCC23726 and growth analysis in nutrient-limited media. (A) Schematic showing
integration of plasmid containing siaT insert (pLR25) into the F.n. chromosome. Positions of Fwd and Rev primers used for confirming integration of plasmid are also
indicated. (B) Agarose gel image with the expected PCR product confirming integration of plasmid into the siaT locus. (C) RT-qPCR analysis of genes flanking siaT in F.n.
shows low expression of transcripts of putative sialic acid catabolism genes downstream of the plasmid insertion site. Difference in expression of each gene between F.n.
WT versusOsiaT was analyzed by the ΔΔCt method using the 16S rRNA gene for normalization. Fwd and Rev primer binding sites are indicated by arrows in the
schematic below the graph. (D) Functional assessment of the WT andOsiaT strains confirms disruption of sialic acid catabolism. Shown is the concentration of sialic acid
(Neu5Ac) remaining in the medium 24 hpi. Sialic acid consumption by F.n. WT andOsiaT was studied in supplemented Columbia media with free sialic acid added. (E)
Growth of F.n. WT andOsiaT in nutrient-limited media with no added carbohydrates (carbs) or with the indicated carbohydrates added. All data shown are
representative of 2 or more independent experiments. The underlying numerical data for this figure can be found in S1 Data. Error bars represent standard deviation from
the mean. Description of the plasmids and cloning vectors used for construction of new suicide plasmid pLR25 can be found in S1 Table. Description of the genes in the
predicted sialic acid catabolic gene cluster can be found in S2 Table. ATCC, American Type Culture Collection; catP, chloramphenicol acetyltransferase; Fwd, forward; F.
n., F. nucleatum; hpi, hours postinoculation; nanA, N-acetylneuraminate lyase; Neu5Ac, N-acetylneuraminic acid; Rev, reverse; RT-qPCR, reverse transcription–
quantitative PCR; siaT, predicted sialic acid transporter; WT, wild type.
https://doi.org/10.1371/journal.pbio.3000788.g002
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glucose, reaching a plateau at an OD600 of>0.6. In contrast, in the medium containing free
sialic acid as the main source of carbohydrate, OsiaT showed a substantial growth defect,
reaching an OD600 of only approximately 0.25, whereas WT grew to an OD600 of>1.0 (Fig
2E). Together, these data demonstrate the genetic basis for sialic acid catabolism in F. nuclea-
tum and illustrate the benefit of sialic acid catabolism under nutrient-limited conditions.
F. nucleatum has restricted access to sialoglycans
Consistent with a previous study showing that 39 cultured F. nucleatum isolates all lacked siali-
dase activity [41], our bioinformatic analysis of F. nucleatum proteomes revealed no putative
sialidases in this taxon. In an in vitro assay, using the abundant BV bacterium and known siali-
dase producer G. vaginalis as a positive control, we found that anaerobically grown F. nuclea-
tum could not cleave a fluorogenic sialic acid substrate (Fig 3A). Along with previous findings,
these results establish that F. nucleatum lacks its own sialidase activity. We therefore hypothe-
sized that its ability to access and utilize sialic acid bound to host glycans for growth would
require exogenous sialidase provided by bacteria living within the same niche (Fig 3B). To test
this, F. nucleatum strains were inoculated in nutrient-limited media with added 30-sialyllactose
(3SL, a trisaccharide glycan containing α2–3–linked Neu5Ac) in the presence or absence of an
exogenous purified sialidase from Arthrobacter ureafaciens. Here, we observed that both F.
nucleatum WT and OsiaT showed little growth in sialoglycan-rich media without exogenous
sialidase. In contrast, upon the addition of sialidase, the WT strain grew more substantially
(reaching an OD600 >0.8) in sialoglycan-containing medium. The OsiaT mutant, unable to
consume sialic acids, continued to exhibit limited growth even in the presence of sialidase
(only reaching an OD600 = approximately 0.4) (Fig 3C). As described in the Methods, derivati-
zation without prior acid hydrolysis measures free Neu5Ac, while derivatization following acid
hydrolysis, which releases bound Neu5Ac from sialoglycans, measures the total Neu5Ac
(Bound Neu5Ac = Total Neu5Ac − Free Neu5Ac). Measurements of the media at the endpoint
showed that sialic acids remained in the bound form in the absence of exogenous sialidase,
precluding F. nucleatum from capitalizing on this resource (Fig 3D). With the addition of siali-
dase, sialic acids were liberated into the free form, but only WT F. nucleatum was able to
deplete the liberated resource. In contrast, OsiaT was unable to deplete sialic acids and did not
receive a growth benefit. While the sialoglycan substrate used here contains α2–3–linked sialic
acids, Arthrobacter and Gardnerella sialidases are able to access both α2–3– and α2–6–linked
sialic acids [34,55]. Together, these data demonstrate that F. nucleatum can access and con-
sume sialic acids from sialo-glycoconjugates, only if sialidase activity from an exogenous
source is available to first liberate sialic acids into the free form.
Sialic acid catabolism prolongs vaginal colonization by F. nucleatum
The above findings supported our hypothesis that sialic acid catabolism may facilitate F. nucle-
atum colonization and persistence within sialidase-producing microbial communities.
Although the vaginal microbiomes of women and laboratory mice are different, our previous
measurements of sialidase activity in mouse vaginal washes suggested that some mice, like
some women, harbor a sialidase-positive vaginal microbiome [31]. However, only approxi-
mately 10% of animals in this prior study had sialidase activity in vaginal washes. To identify a
vendor whose C57BL/6 mice had a more uniform sialidase-positive phenotype, vaginal washes
from animals purchased from multiple vendors were tested for sialidase activity. Endogenous
vaginal sialidase activity was present in most mice from Envigo but was rarely detectable in
mice from 3 other vendors (S3A Fig). Furthermore, Envigo mice had even more vaginal siali-
dase activity after treatment with β-estradiol, whereas mice from Jackson were sialidase-
PLOS BIOLOGY Fusobacterium and the vaginal microbiota
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negative with or without β-estradiol treatment (S3B Fig). This is relevant because our mouse
model employs β-estradiol treatment, like most bacterial vaginal inoculation models [31,56–
59].
To investigate whether sialidase activity in vaginal washes was of bacterial origin, we pro-
filed the composition of the vaginal microbiotas of Jackson and Envigo mice. To increase the
available biomass, we pooled vaginal washes from cohoused mice (4 pools/vendor), and a por-
tion of each vaginal wash pool was cultured anaerobically, then frozen in cryoprotectant (S1
Fig 3. F.n. accesses bound sialic acid from glycan chains, but only when liberated by exogenous sialidases. (A) Analysis of cell-associated sialidase activity of
anaerobically cultured G. vaginalis JCP8151B and F.n. ATCC23726 strains using fluorogenic 4MU-Neu5Ac substrate. (B) Working hypothesis: sialidase producers in
the vaginal microbial community release free sialic acids (red diamonds) from host glycoconjugates, which may be accessed by F.n., which does not produce sialidase.
More information about F.n. genes shown in the predicted sialic acid catabolic gene cluster and the enzymes they encode can be found in S2 Table. (C) Growth of F.
n. ATCC23726 WT andOsiaT in nutrient-limited media with added 3SL, in the absence of sialidase (no sialidase) or presence of exogenous A.u. sialidase. (D)
Concentrations of remaining free and total sialic acid (Neu5Ac) in nutrient-limited media (with added 3SL, from experiment shown in C) that was either
uninoculated or inoculated with F.n. WT orOsiaT strain (in absence and presence of A.u. sialidase). Total and free sialic acid content was measured at approximately
48 h postinoculation. Bound sialic acids are inaccessible to F.n. except in the presence of exogenous sialidase. All data shown are representative of 3 independent
experiments. The underlying numerical data for this figure can be found in S1 Data. Error bars represent standard deviation from the mean. ATCC, American Type
Culture Collection; A.u., A. ureafaciens; F.n., F. nucleatum; NanA, N-acetylneuraminate lyase; Neu5Ac, N-acetylneuraminic acid; OD, optical density; PBS,
phosphate-buffered saline; siaT, predicted sialic acid transporter; WT, wild type; 3SL, 30-sialyllactose; 4MU, 4-methylumbelliferone.
https://doi.org/10.1371/journal.pbio.3000788.g003
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Schematic). Corroborating our findings in individual vaginal washes, microbiota pools (cul-
tured vaginal wash) from Envigo mice, but not Jackson mice, had high sialidase activity (S3C
Fig). The presence of sialidase activity in mixed cultures from Envigo mice is consistent with
the hypothesis that sialidase is microbial and not host-derived. To further validate this hypoth-
esis, we analyzed the mouse vaginal microbiota by sequencing the V1–V2 region of the gene
encoding the 16S ribosomal subunit (S3D Fig) (see Methods for V1–V2 rationale). DNA was
extracted from both the original (uncultured) pooled wash material and from viable communi-
ties of bacteria (microbiota pools) derived from the cultured vaginal wash material (S1 Sche-
matic). In addition to the 16S sequencing analysis, the cultured microbiota pools were also
plated on agar media, and the resulting colonies were picked into 96-well plates to perform sia-
lidase activity assays. PCR and sequencing were also performed to identify colonies. Sequenc-
ing revealed that several of the uncultured vaginal wash pools and ex vivo-cultured
communities from Envigo mice contained Enterococcus casseliflavus/gallinarum, whereas the
corresponding samples from Jackson mice did not. Notably, colonies of E. gallinarum and Bac-
teroides spp. from cultured vaginal wash pools from Envigo mice expressed sialidase activity
(S3E Fig and S3F Fig). Furthermore, we previously isolated sialidase-positive E. gallinarum
from mouse vaginal washes that contained sialidase activity [20,31]. These findings are consis-
tent with differences in vaginal sialidase activity between mice from the different vendors and
confirm that C57BL/6 mice from Envigo exhibit vaginal sialidase activity arising from the
endogenous microbiota. Finally, we note that estrogenized mice from Envigo were consistently
sialidase-positive in 4 independent studies of mice purchased over 2 years and were therefore a
relevant model to test our hypothesis.
To determine whether the ability to catabolize sialic acid contributes to F. nucleatum colo-
nization or persistence within sialidase-producing microbial communities, Envigo mice were
vaginally inoculated with F. nucleatum WT or OsiaT, and vaginal washes were collected longi-
tudinally for several weeks (Fig 4A). Before inoculation, both the infection groups had similar
amounts of sialidase activity (Fig 4B). As early as 72 h postinoculation (hpi), and later at 6 days
postinoculation (dpi) up to 8 dpi, OsiaT had significantly lower titers than WT in Envigo mice
(Fig 4C and S4 Fig). Sufficient vaginal wash material was available for sialic acid measurement
at 8 dpi from some of the mice in each experimental group. Free sialic acid levels were similar
between WT- and OsiaT-inoculated mice. However, total sialic levels were lower in mice colo-
nized with WT- compared to OsiaT-inoculated mice (S4 Fig). The latter comparison was
underpowered with the number of samples available and did not reach statistical significance
(P = 0.19). However, the lower levels of total sialic acid in mice with F. nucleatum WT are con-
sistent with a depletion of sialic acid, a phenotype also observed in women with BV. Further-
more, OsiaT exhibited a significant defect in vaginal persistence relative to the WT strain
(P = 0.02; Fig 4D). Similar to Envigo mice, F. nucleatum was also able to colonize sialidase-neg-
ative mice from Jackson Labs. However, there was no detectable benefit afforded by sialic acid
catabolism in this setting, either in overall bacterial burden or persistence (S5 Fig). We con-
clude from these experiments that the ability to catabolize sialic acid benefits F. nucleatum col-
onization and persistence in a sialidase-positive vaginal environment.
F. nucleatum enhances sialidase activity in mouse vaginal communities
While working with the mouse model, we observed that vaginal sialidase activity waned rap-
idly after arrival in our facility, both in mice that received mock inoculations (Fig 5A) and
those inoculated with a different urogenital pathogen such as E. coli (S6 Fig). In contrast, when
inoculated with F. nucleatum, vaginal sialidase activity was maintained for a significantly lon-
ger duration (Fig 5A). Additionally, inoculation of WT F. nucleatum helped to maintain higher
PLOS BIOLOGY Fusobacterium and the vaginal microbiota
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000788 August 25, 2020 8 / 36
levels of vaginal sialidase for a longer duration as compared to inoculation with OsiaT (Fig
5B). While sialidase activity was equivalent between WT- and OsiaT-inoculated mice at 1 dpi
(Fig 5C), by 6 dpi sialidase activity was significantly lower in vaginal washes from mice inocu-
lated with OsiaT compared to WT. These data suggest that besides receiving benefit from the
sialidase-producing microbiota, F. nucleatum also exerts influence of its own by supporting
the sialidase-positive vaginal microbiota (Fig 5D).
To investigate the effect of F. nucleatum on sialidase activity produced by vaginal communi-
ties in a more reduced system, we investigated the responses of mouse vaginal microbiotas to
Fig 4. Sialic acid catabolism encourages F. nucleatum colonization in mice with sialidase-positive vaginal microbiomes. (A)
Time course of vaginal colonization with F. nucleatum ATCC23726. Open circles indicate vaginal wash collection which were used
to monitor colonization status and sialidase activity at all time points. (B) Analysis of sialidase activity in vaginal washes of Envigo
mice before inoculation with F. nucleatum (P = 0.73, Mann–Whitney U test). (C) CFU enumeration of F. nucleatum WT andOsiaT
in vaginal washes collected at the indicated time points from Envigo mice. ��P< 0.01, Mann–Whitney. (D) Time course of vaginal
colonization with F. nucleatum WT andOsiaT mutant in Envigo mice. Percent of mice colonized (y axis) was monitored on day 1
and every 2 days thereafter up to 38 dpi (x axis). For Kaplan–Meier analysis, mice were considered cleared when no CFUs were
detected in undiluted wash at 2 consecutive time points. Statistical significance was assessed by Gehan–Breslow–Wilcoxon test,
�P< 0.05. The graphs represent combined data from 2 independent experiments, with 10 mice per group in each experiment. The
underlying numerical data for this figure can be found in S1 Data. ATCC, American Type Culture Collection; CFU, colony-forming
unit; dpi, days postinoculation; E, estrogenization; IP, intraperitoneal; siaT, predicted sialic acid transporter; WT, wild type.
https://doi.org/10.1371/journal.pbio.3000788.g004
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F. nucleatum (WT or OsiaT) in an ex vivo anaerobic culture model. As described in the Meth-
ods (Fig 6A and S1 Schematic), microbial communities generated from vaginal washes of mice
were cultured anaerobically in the presence or absence of equal amounts of F. nucleatum WT
orOsiaT, and sialidase activity was measured after overnight culture (approximately 16 h). In
cultures from all 4 microbiota pools, those receiving F. nucleatum (either WT or OsiaT) had
significantly higher levels of sialidase activity than the identical microbiota cultured without F.
nucleatum (Fig 6B). This assay was performed under nutrient replete conditions in supple-
mented Columbia media in which WT and OsiaT strains grew equally well, resulting in
Fig 5. Microbiota-derived sialidase activity in the mouse vagina is sustained by F.n. colonization. (A) Persistence of sialidase activity in C57BL/6 mice (Envigo)
inoculated either with WT F.n. or vehicle only. Mice were considered sialidase-negative if sialidase activity levels in vaginal washes were below 0.01 μM/min (using
the 4MU-Sia assay) for 3 sequential time points. Data are shown from a single experiment with a total of N = 20 animals. �P< 0.02, log–rank test. (B–C) Sialidase
activity in vaginal washes from 1 to 8 dpi from individual animals purchased from Envigo, estrogenized, and inoculated with either WT orOsiaT F.n. The graphs
represent combined data from 2 independent experiments, with 10 mice per group in each experiment. Data points with negative values were set to 0.001 to
represent them on the log scale. (B) Sialidase activity at later time points were compared to day 1 values using the Friedman test, with correction for multiple
planned comparisons using Dunn’s test. (C) Same experiment and data as shown in B but analyzed to compare between WT- orOsiaT-inoculated animals at each
time point using the Mann–Whitney test. On all graphs, �P< 0.05, ��P< 0.01, ����P< 0.0001. (D) Sialidase producers in the vaginal microbial community release
free sialic acids (red diamonds) from host glycoconjugates, providing benefits to F.n. Hypothesis: at the same time, vaginal community members themselves derive
benefits from F.n., leading to sustained sialidase activity in these communities. Sialidases are represented as scissors. The underlying numerical data for this figure
can be found in S1 Data. dpi, days postinoculation; F.n., F. nucleatum; siaT, predicted sialic acid transporter; WT, wild type; 4MU, 4-methylumbelliferone.
https://doi.org/10.1371/journal.pbio.3000788.g005
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indistinguishable final colony-forming unit (CFU) titers (Fig 6C). Together with the result in
Fig 6B, this suggests that WT and OsiaT, when present at the same levels, result in similar
increases in microbiota-derived sialidase activity. Variation of the starting inoculum of both F.
nucleatum strains revealed a dose-dependent effect on microbiota-derived sialidase activity
(Fig 6D). These data suggest that in mice, the divergence of sialidase activity in groups receiv-
ing WT versus OsiaT arising after 6 days (Fig 5C) resulted from different “doses” of F.
Fig 6. Ex vivo interaction between F.n. and the mouse vaginal microbiota leads to enhanced sialidase activity. (A) Microbiotas from vaginal washes were collected
from mice prior to inoculation in Fig 4B, pooled (by cage), cultured, and frozen (S1 Schematic, Step 1). Bacteria were recovered from frozen microbiota pools by
streaking them on supplemented Columbia blood plates anaerobically and incubating for 24 h at 37˚C. Microbial growth was gently scraped from these plates and
resuspended in liquid media to prepare OD-normalized inocula and cocultured with F.n. WT orOsiaT overnight (approximately 16 h). (B) Sialidase activity in
microbiota pools from Envigo mice, cultured in the presence or absence of F.n. Each “microbiota pool” consists of a cultured vaginal community from pooled vaginal
wash of 4–5 cohoused mice. Wilcoxon paired-sign rank test was used for pairwise comparison. Data shown are combined from 4 independent biological replicates
with 7–8 technical replicates for each microbiota pool. �P< 0.05, ��P< 0.01. (C) F.n. titers after overnight growth with microbiota pools from Envigo mice. (D) Dose-
dependent boost in sialidase activity in microbiota pools from Envigo mice, cultured in the presence or absence of F.n. (inocula high to low: OD600 0.10 or 0.025 or no
F.n.). Line in the box indicates median value. Data shown are representative of 3 independent experiments. The underlying numerical data for this figure can be found
in S1 Data. CFU, colony-forming unit; F.n., F. nucleatum; OD, optical density; siaT, predicted sialic acid transporter; WT, wild type.
https://doi.org/10.1371/journal.pbio.3000788.g006
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nucleatum (arising as of day 3; Fig 4C and S4 Fig) rather than a specific feedback loop involv-
ing sialic acid catabolism.
F. nucleatum enhances sialidase activity and facilitates growth of G.
vaginalis in human vaginal communities
A significant limitation of using mice to model interactions within the vaginal microbiome is
that they have distinctly different vaginal microbiotas compared to humans. Thus, our findings
in mice led us to wonder whether F. nucleatum also leads to increased sialidase activity in
human vaginal microbial communities. To test whether F. nucleatum stimulates sialidase
activity in human vaginal microbial communities, vaginal swabs were collected from women,
and living bacterial communities were then transported anaerobically to the lab and immedi-
ately prepared for viable cryopreservation under anaerobic conditions (S2 Schematic: Step 1).
Next, vaginal communities from 21 women who had sialidase activity in their aerobic vaginal
swab eluates (S7 Fig) were thawed and cultured anaerobically in the presence or absence of F.
nucleatum (Fig 7A and S2 Schematic: Step 2). As we observed with mouse microbial commu-
nities, human vaginal communities cultured with added F. nucleatum had significantly higher
levels of sialidase activity after culture than the identical community cultured without F. nucle-
atum (Fig 7B).
There are at least 2 possible explanations for the enhanced sialidase activity observed upon
addition of F. nucleatum to vaginal communities. First, if F. nucleatum drives sialidase activity
in communities by promoting the growth of sialidase-producing bacteria, it would indicate a
mutualistic relationship between F. nucleatum and sialidase-producing bacteria. Alternatively,
F. nucleatum could induce sialidase expression without promoting growth of sialidase-produc-
ing bacteria, which would suggest a commensal or parasitic relationship between F. nucleatum
and sialidase-producing bacteria (depending on whether the latter were unaffected or
harmed). G. vaginalis is believed to be a primary source of sialidase activity in vaginal fluids of
women with BV [31,60]. To further investigate the potential benefit of F. nucleatum to siali-
dase-producing bacteria, we used community profiling to assess the relative levels and qPCR
for absolute quantification of G. vaginalis in human vaginal communities. Following DNA
extraction from vaginal communities cultured with or without F. nucleatum, we performed
community profiling based on the gene encoding the 16S ribosomal subunit (V4 region).
When F. nucleatum was present, G. vaginalis occupied a significantly larger fraction of the
endogenous community compared to identical microbiotas cultured under the same condi-
tions but without F. nucleatum (Fig 7C). Next, we used a previously validated qPCR assay
based on the Gardnerella Translation elongation factor Tu (tuf) gene encoding elongation fac-
tor Tu [61], G. vaginalis was detected at significantly higher levels in communities cultured
with F. nucleatum compared with the same communities cultured without addition of F. nucle-
atum (Fig 7D). These data strongly suggest that F. nucleatum supports the development of dys-
biotic vaginal communities that become enriched with Gardnerella and sialidase activity.
To more specifically study the effect of F. nucleatum on G. vaginalis, we established an in
vitro coculture system. G. vaginalis (strain JCP8151B) and F. nucleatum were coinoculated
across a range of inocula doses into supplemented Columbia broth, which is nutrient-rich but
inadequate for growth of G. vaginalis. Cultures in 96-well plates were incubated anaerobically
at 37˚C overnight. Inoculated alone under these conditions, G. vaginalis could not be recov-
ered alive (Fig 8A, plotted at one-half the detection limit). However, coinoculation with F.
nucleatum resulted in significant growth of G. vaginalis (>4 orders of magnitude), which
increased further with higher inocula of F. nucleatum. Experiments using filter-sterilized (cell-
free) spent media from cultures of F. nucleatum revealed a similar boost in G. vaginalis CFU,
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suggesting that the G. vaginalis growth-promoting factor or factors are present in the cell-free
supernatant and do not require live bacteria (Fig 8B). There was a dose-dependent increase in
G. vaginalis titers with increasing proportions of F. nucleatum spent supernatant. These data
suggest that F. nucleatum may secrete one or more factors that have a strong growth-promot-
ing effect on G. vaginalis.
Viable recovery of G. vaginalis in monoculture could also be improved by increasing the
dose of the G. vaginalis inoculum. However, across the entire range of G. vaginalis inocula
used, the addition of F. nucleatum improved recovery by orders of magnitude (as few as 1, as
Fig 7. F.n. supports Gardnerella growth and stimulates sialidase activity within human vaginal communities. (A–D) Human vaginal
communities from 21 individual women were used. (A) Microbial communities were eluted from vaginal swabs under anaerobic conditions in
nutrient-rich media. Communities with potential sialidase producers (sialidases are represented as scissors) were cultivated anaerobically in
supplemented Columbia media in the presence or absence of added F.n. (B) Sialidase activity was measured following anaerobic culture.
Negative values were set to 0.0018 (lowest positive value) to depict them on the log scale. Graphs show data combined from 2 independent
experiments. (C) Relative abundance of G.v. in cultured human vaginal communities. Sequencing of the gene encoding the V4 region of 16S
rRNA was used to estimate proportions of G.v. in the microbial communities. (D) Quantitation of G.v. in cultured human vaginal
communities by tuf qPCR. In each case, statistical comparison between the 2 groups was performed using Wilcoxon matched-pairs signed
rank test. The underlying numerical data for this figure can be found in S1 Data. On all graphs, ���P< 0.001, ����P< 0.0001. F.n., F.
nucleatum; G.v., G. vaginalis; qPCR, quantitative PCR; tuf, Translation elongation factor Tu.
https://doi.org/10.1371/journal.pbio.3000788.g007
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Fig 8. Enhanced growth of G.v. in cocultures with F.n. (A) Analysis of G.v. growth by CFU enumeration in anaerobic
cocultures with or without F.n. in supplemented Columbia medium. Data shown are combined from 2 independent
experiments, with 3 technical replicates each. (B) Growth of G.v. in media with whole F.n. or spent cell-free supernatant from F.
n. culture. Data shown are combined from 2 independent experiments, with 2 technical replicates each. (C) Dose-dependent
effect of F.n. on G.v. growth in supplemented Columbia medium. Data shown are combined from 9 independent experiments.
Note that at low inocula, G.v. was not detectable under these conditions in the absence of F.n. In this case, G.v. levels were
plotted at one-half the LOD (LOD = 200 CFU/mL). For A–C, data are represented in box plot format with whiskers of min and
max. Statistical analysis: Kruskal–Wallis followed by Dunn’s multiple comparisons test. (D) Sialidase activity in G.v. cultured
overnight with F.n. WT in supplemented Columbia medium. Heat map data are representative of 2 independent experiments.
Inoculum range—F.n. OD600: 0, 0.00625, 0.0125, 0.025, 0.05, 0.1; G.v. OD600: 0, 0.000781, 0.001562, 0.003125, 0.00625, 0.0125,
0.025, 0.05. The underlying numerical data for this figure can be found in S1 Data. On all graphs, �P< 0.05, ��P< 0.01,
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many as 7; Fig 8C). G. vaginalis viability after overnight incubation in this system required at
least a 20,000-fold higher inoculum in monoculture compared to what could be achieved in
cocultures with F. nucleatum. Comparing sialidase activity across a spectrum of G. vaginalis
inocula doses (up to OD600 0.05) revealed no detectable sialidase activity when the organism
was grown without F. nucleatum (Fig 8D). Even a relatively small inoculum of F. nucleatum
resulted in measurable sialidase activity in the cultures. Also, sialidase activity could be rescued
in cultures inoculated with progressively lower levels of G. vaginalis by adding higher amounts
of F. nucleatum. As with WT F. nucleatum (Fig 8), dose-dependent increases in sialidase activ-
ity were also observed when G. vaginalis was cocultured with OsiaT F. nucleatum (S8 Fig).
This is similar to observations made in coculture experiments with mouse vaginal communi-
ties in which both WT and OsiaT had similar boosting effects on sialidase activity (Fig 6B).
These findings further illustrate that the growth benefit to Gardnerella is not directly tied to F.
nucleatum sialic acid catabolism. This also suggests that while both F. nucleatum and G. vagi-
nalis may benefit from cohabitation, their mutualism is not obligate, but rather facultative.
However, in a polymicrobial community with shared and limited nutrient resources, such a
relationship could become a necessary tool for survival and persistence.
Discussion
A growing number of literature reports describe the contents and dynamics of the human vaginal
microbiome, but we still know surprisingly little about how vaginal dysbiosis develops or why
women with BV are more likely to harbor potentially pathogenic vaginal bacteria. One of the pre-
vailing concepts is that an absence of secreted antimicrobial activities produced by “healthy” lac-
tobacilli creates a permissive vaginal environment in which opportunists can overgrow [7,14,62].
Here, we provide evidence for a different type of relationship—a mutualism that actively rein-
forces new pathogen colonization (F. nucleatum) while promoting the expansion of features
linked with dysbiosis (G. vaginalis, sialidase). Our analysis of sialic acid catabolism by F. nuclea-
tum suggests that the presence of sialidase activity in the vagina during BV may allow F. nuclea-
tum to capitalize on the increased availability of free sialic acid. Additionally, experiments in the
mouse model further support the role of sialic acid metabolism in the persistence of F. nucleatum
in a sialidase-positive environment in vivo. We also discovered that a mutually beneficial relation-
ship exists between F. nucleatum and sialidase-producing bacteria within vaginal microbiomes.
Both ex vivo and in vitro coculture studies show that F. nucleatum can support the outgrowth of
G. vaginalis, one of the most common and abundant species that overgrows in BV, suggesting an
important role of interspecies crosstalk in shaping the dynamics of the vaginal microbiome.
Several features of the mouse model, together with considerations of human physiology,
have guided our interpretations of the in vivo data. Sialic acid catabolism provided a benefit to
F. nucleatum in specific contexts. However, the organism initially colonized 100% of mice,
even in the absence of sialidase, suggesting that sialic acid catabolism is not an absolute
requirement for initial F. nucleatum vaginal colonization in mice. Thus, F. nucleatum must be
using other strategies to colonize the vagina in the sialidase-negative setting. Indeed, the mech-
anisms of colonization may be distinct in mice from different vendors, in which competition
for resources with different microbes may have distinctly different outcomes. Other models of
vaginal infection have also yield different results depending on the composition of the endoge-
nous microbiota, as illustrated in a recent study of Group B Streptococcus [63]. Furthermore,
because of the diverse potential sources of bacterial sialidase, the compositional and physiological
���P< 0.001. CFU, colony-forming unit; F.n., F. nucleatum; G.v., G. vaginalis; LOD, limit of detection; n/a, not applicable; OD,
optical density; WT, wild type.
https://doi.org/10.1371/journal.pbio.3000788.g008
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complexity of vaginal communities, and insufficient experimental tools for genetic manipulations
in many fastidious vaginal anaerobes, we lack precise experimental control of sialidase within
bacterial communities. In addition to mutualistic relationships among members of the dysbiotic
microbiota, antagonistic interactions probably also impact the vaginal environment in humans.
For example, women without BV, who lack sialidase activity, also have lactobacilli that create an
environment of high lactic acid and low pH [20,64], which likely contributes to the exclusion of
Fusobacterium. Together, these considerations provide an overarching rationale that may help
explain why F. nucleatum has been isolated at approximately 6-fold higher rates among women
with BV compared to those without (54% versus 9.4%, respectively) [3]. Future studies on the
ecology of vaginal microbial communities will be necessary to map and evaluate the magnitude
of synergistic and antagonistic interactions connecting species within vaginal communities.
Although it is not known how women acquire vaginal F. nucleatum, the ubiquitous presence
of F. nucleatum in the mouth points to orovaginal contact as one plausible route of vaginal
exposure. Indeed, several studies suggest orogenital contact is a risk factor for BV or vaginal
community features consistent with dysbiosis, such as low levels of Lactobacillus or high levels
of G. vaginalis [65–69]. Our data suggest that such exposure could lead to outgrowth of G. vagi-
nalis, even if Fusobacteria are introduced at relatively low numbers. In light of these findings,
future studies should evaluate whether exposure of the vagina to microbes from other body sites
(for example, oral, rectal, penile) may enhance dysbiotic features of the vaginal microbiome.
F. nucleatum often cohabitates with sialidase-producing bacteria at mucosal niches such as
the oral cavity, gut, and vagina [42–46]. Thus, our findings also have pertinence for other dys-
bioses and infections where Fusobacterium species have been implicated. For example, F. nucle-
atum is a ubiquitous member of the oral microbiome in humans but also overgrows and plays
key roles in the multispecies biofilm seen in periodontal disease. Some of the members of this
biofilm are also sialidase producers [70–72]. As observed in BV [31], depletion of sialic acids
from the oral mucosa has been observed in gingivitis [73], another condition associated with
overgrowth of F. nucleatum. Additionally, F. nucleatum has also been identified as a contributor
in colorectal cancer [74]. Colorectal tumors that have metastasized to other locations in the
body commonly contain not only F. nucleatum but also species of Bacteroides, which are siali-
dase producers [75]. In fact, sialidase-producing members of the Bacteroidetes often cohabitate
with Fusobacterium in abscesses, amniotic fluid infections, and polymicrobial bacteremia/sepsis
[76–80]. Together with the data presented here, these findings suggest that F. nucleatum may
benefit from sialidase-producing bacteria during disease processes throughout the human body.
In conclusion, these studies provide the first direct evidence that mutual benefit, made pos-
sible in part through metabolite cross-feeding, can promote pathogen colonization of the
vagina and encourage features of vaginal dysbiosis. These findings may help explain why
women with BV are more likely to be vaginally colonized with potential pathogens linked with
intrauterine infection and adverse health outcomes. Although the present work greatly
advances our understanding of bacterial relationships that may influence the development of
dysbiosis, additional study is needed to apply these principles to the prevention or treatment
of dysbiosis in women. Additional investigations of the relationships between vaginal microbes
may further reveal the metabolic networks that connect bacterial species within diverse vaginal
communities and point to potential target pathways to disrupt these relationships.
Methods
Ethics statement
Animal research: mouse experiments were carried out in strict accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory Animals. The protocol was
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approved by the Institutional Animal Care and Use Committee (IACUC) of Washington Uni-
versity School of Medicine (Protocol Number: 20170081).
Human subject research: vaginal specimens collected from women who participated in the
Urogenital Community (UC) Bank project, an archive of living microbial communities estab-
lished for translational microbiome research, were used for these studies, according to Wash-
ington University in Saint Louis IRB-approved protocol (protocol number, 20170412; PI,
Amanda Lewis). A written informed consent was obtained from all participants enrolled in the
UC Bank project. Nonpregnant women seeking care at the North Central Community Health
Center, a no-fee clinic operated by the St. Louis County health department, were enrolled in
the UC Bank project. While no specific racial or demographic group was sought or excluded
for participation, >90% of women enrolled self-identified as black, a demographic very similar
to the community neighboring the clinic. Women with known human immunodeficiency
virus or hepatitis C virus or with recent antibiotic use (past 3 weeks) were excluded.
Bacterial strains and growth conditions
For a list of bacterial strains, plasmids, and primers, see S1 Table. WT strains of E. coli (TOP10)
[Invitrogen, Carlsbad, CA, USA] and MG1655, UTI89, and CFT073 [provided by Dr. Scott
Hultgren] were grown in lysogeny broth (LB) at 37˚C unless otherwise noted. For plasmid main-
tenance, ampicillin was used at 100 μg/mL and chloramphenicol at 20 μg/mL. SmR isolate of G.
vaginalis JCP8151B [31,81], hereafter referred to simply as G. vaginalis, was cultured in NYCIII
media containing 10% heat-inactivated horse serum at 37˚C in an anaerobic chamber unless
stated otherwise. F. nucleatum strains ATCC25586, ATCC23726, and ATCC10953 were obtained
from ATCC (Manassas, VA, USA). Strains JMP2A, FQG51A, JMSY1, JMH52, SYJL4, JM6, and
JM4 [50] were provided by Dr. Justin Merritt. ATCC23726 is the primary WT strain background
used to model interaction with sialidases and the microbiome. As described below, a spontaneous
SmR mutant of ATCC23726 was isolated and, unless otherwise indicated, was used in all experi-
ments. All fusobacterial strains, unless stated otherwise, were grown at 37˚C in an anaerobic
chamber in Columbia broth supplemented with hemin (5 μg/mL) and vitamin K3 (1 μg/mL),
referred to as “supplemented Columbia” (contains glucose as well as sialoglycans from animal
ingredients). For clarity, we have avoided the term “supplemented” to refer to the addition of
other components to media. When grown on solid media, supplemented Columbia blood agar
plates were used (containing 5% defibrinated laked sheep blood and 1.5% agar). For some experi-
ments, we developed a nutrient-limited media that contains base components present in Colum-
bia media, including proteose peptone #3 (1% w/v), sodium chloride (0.5% w/v), and HEPES
(16.8 mM). Although the requirements of F. nucleatum do not allow us to do single-carbon–
source experiments, this simple medium was used in a similar manner with or without added
carbohydrate sources and is referred to throughout the text as “nutrient-limited” media.
Identification of putative sialate lyase (NanA) homologs in F. nucleatum
A sequence similarity search was conducted using the protein blast (BLASTp ver. 2.2.31+) pro-
gram from the BLAST suite [82]. Amino acid sequences of NanA from E. coli MG1655 (Gen-
Bank: AAC76257.1) and F. nucleatum subsp. nucleatum ATCC23726 (GenBank: EFG95907.1)
were used as query to the nonredundant (NR) protein sequences database for F. nucleatum
(taxid: 851). Any hits with an E-value less than 1 × 10−9 were considered significant.
Free sialic acid foraging by F. nucleatum
E. coli (Top 10) was cultured aerobically in LB medium with added sialic acid (Neu5Ac,
100 μM). Fusobacteria (S1 Table) were cultured anaerobically in supplemented Columbia
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media with added sialic acid (Neu5Ac, 100 μM, A0812; Sigma-Aldrich, St. Louis, MO, USA),
which was also used as the uninoculated medium control in this experiment. After 24–48 h of
growth, media supernatant was separated from bacterial cells by centrifugation at 15,000 × g.
In some experiments, collected media supernatant was filtered using a 10,000 molecular
weight cutoff (MWCO) filter. Samples were then processed for 1,2-diamino-4,5-methylene-
dioxybenzene (DMB) derivatization for measurement of free sialic acid (Neu5Ac) remaining
in the medium, as described below.
Measurement of total and free sialic acids by DMB-HPLC
Derivatization and quantitation of sialic acids by HPLC was carried out as previously described
[31,83–86]. Briefly, total sialic acids were measured by first releasing any bound sialic acids
using mild acetic acid hydrolysis (2 N acetic acid for 3 h at 80˚C), followed by derivatization of
total sialic acids with DMB as described below. Alternatively, free sialic acid levels were mea-
sured by DMB derivatization without prior acid hydrolysis. The derivatization reaction
requires that sialic acids be in the monosaccharide form. Thus, the concentration of bound
sialic acids is measured indirectly (bound = total − free). Reaction conditions for DMB deriva-
tization were 7 mM DMB, 22 mM sodium thiosulfite, 0.75 M 2-mercaptoethanol, and 1.4 M
acetic acid for 2 h at 50˚C. Derivatized samples were injected into a Waters HPLC (Milford,
MA, USA) equipped with a reverse-phase C18 column (Tosoh Bioscience, Tokyo, Japan) and
eluted using isocratic conditions at 0.9 ml/min using 8% methanol, 7% acetonitrile in water.
An online fluorescence detector (Waters) was set to excite at 373 nm and detect emission at
448 nm. Peak integrations were used to quantitate sialic acid content by referencing a standard
curve of pure sialic acid (Neu5Ac; Sigma-Aldrich) derivatized in parallel.
Complementation of E. coli MG1655 sialate lyase mutant ΔnanA and
growth comparison
MG1655 nanA was amplified with the primers MG1655 nanA F Nco and MG1655 nanA R Pst
(S1 Table). The PCR product was desalted, digested with the restriction enzymes NcoI and
PstI, and ligated into the NcoI and PstI sites of pTrc99A to create pLR7. F. nucleatum
ATCC23726 nanA was amplified with the primers Fuso nanA F Nco and Fuso nanA his R
Bam. Following desalting and digestion with NcoI and BamHI, the amplicon was cloned into
the same sites in pTrc99A, creating pLR10. The E. coli MG1655 ΔnanA mutant LSR4 was
described previously [36]. LSR4 was transformed with pLR7, pLR10, or the vector control
(pTrc99A) (S1 Table). The 3 strains were grown to an OD600 of 1.0 in LB broth containing
100 μg/mL ampicillin. Then, each strain was diluted 1:100 into M63 media lacking glycerol
and with added Neu5Ac (15 mM). The OD600 was measured every 10 min at 37˚C in a 96-well
plate (flat bottom; Greiner Bio-One, Monroe, NC, USA) in a TECAN M200 plate reader with
10 s of orbital shaking at the beginning of each time point.
Sialate lyase assay by complementation of mutant E. coli
The E. coli ΔnanA mutant (LSR4) containing pLR7 (E. coli MG1655 nanA), pLR10 (F. nuclea-
tum nanA), or empty vector control (pTrc99A) was grown by shaking at 37˚C in 35 mL Circle
Grow broth with 100 μg/mL ampicillin to an OD600 of 1.0. Cultures were then transferred to
room temperature, induced with 0.2 mM IPTG, and grown by shaking overnight. By the next
morning, cultures had grown to an OD600 of approximately 4.0. Next, 25 ml of each culture
was centrifuged at 12,000 × g for 10 min, and the cells were resuspended in 800 μL PBS. Cell
suspensions were sonicated on ice for 40 s in 1-s bursts at 24% amplitude in a Sonic Dismem-
brator (Thermo Fisher Scientific, Waltham, MA, USA). Insoluble debris was removed by
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centrifugation at 15,000 × g for 10 min, and 90 μL of each supernatant was mixed with 10 μL of
1 mM Neu5Ac for a final concentration of 100 μM. Mixtures were incubated at 37˚C, and at
each time point, 10-μL samples were removed, diluted 5× in water, and frozen at −20˚C prior
to analysis by DMB-HPLC.
Isolation of an SmR mutant of F. nucleatum for selective enumeration
F. nucleatum ATCC23726 was cultured anaerobically overnight in supplemented Columbia
media at 37˚C. Cultured bacteria (20 mL) were pelleted by centrifugation at 16,000 × g for 10
min at room temperature, resuspended in 1 mL PBS, and plated on supplemented Columbia
blood plates with 1 mg/mL streptomycin sulfate to select for spontaneous SmR colonies. After
2 days, SmR colonies from Columbia plates (with strep) were cultured in supplemented
Columbia broth. The SmR strain was used for all experiments with the exception of Fig 1A.
Mutation of the rpsL gene (encoding the ribosomal protein S12) in the F. nucleatum
ATCC23726-SmR strain was confirmed by colony PCR and DNA sequencing.
Mutagenesis targeting sialic acid consumption via siaT in F. nucleatum
ATCC23726
Restriction endonucleases, Phusion DNA polymerase, and T4 ligase were obtained from New
England Biolabs (Ipswich, MA, USA). First, a suicide vector was constructed using the origin
of replication from pUC19 and the chloramphenicol acetyltransferase gene (catP) from
pJIR418 (S1 Table). Briefly, the origin of replication was amplified from pUC19 using primers
pUC19 ori F Sac Kpn Nco and pUC19 ori R Bgl2. The catP gene from pJIR418 was amplified
with primers catP F Bgl2 and catP R Bam Pst Nco. The 2 amplicons were desalted, digested
with NcoI and BglII, and ligated together, resulting in pLR23. A 0.5-kb internal fragment of F.
nucleatum siaT was amplified from ATCC23726 chromosomal DNA with the primers 23726
nan F Nco and 23726 nanR Sac. Following desalting, this PCR product and pLR23 were
digested with NcoI and SacI and ligated together, creating pLR25. The SmR strain of F. nuclea-
tum ATCC23726 was used as the background for the siaT mutation. A starter culture of this
strain was diluted 1:1,000 into 10 mL supplemented Columbia broth and grown overnight in
the anaerobic chamber at 37˚C. Bacteria were then pelleted at 12,000 × g for 10 min and
washed twice in 1 ml of 1 mM MgCl2 containing 10% glycerol. The bacteria were washed twice
more in 1 mM MOPS with 20% glycerol and resuspended in 100 μl of the same buffer. Next,
20 μg of purified pLR25 was mixed with the above suspension and incubated on ice for 10
min. The suspension was then transferred to a cuvette with a 0.1-cm gap and electroporated in
an Eppendorf Electroporator 2510 (Eppendorf, Enfield, CT, USA) set to 2.5 kV. Bacteria were
recovered anaerobically for 5 h in supplemented Columbia broth with added MgCl2 (1 mM) at
37˚C, then plated on supplemented Columbia agar with 5 μg/mL thiamphenicol. Plasmid inte-
gration at the desired locus was confirmed by colony PCR using the primers 23726 nan test F1
and pLR24 50 F. The mutant strain is referred to as F. nucleatum OsiaT.
RT-qPCR transcript analysis for genes flanking siaT in F. nucleatum
F. nucleatum WT and ΩsiaT were grown anaerobically to exponential phase in supplemented
Columbia broth at 37˚C. RNA was isolated using PureLink RNA isolation kit (Ambion, Aus-
tin, TX, USA) according to the manufacturer’s instructions and treated with 2.7 Kunitz units
of DNase (Qiagen, Hilden, Germany) per microgram of RNA. cDNA was synthesized using a
high-capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific) following the manu-
facturer’s protocol. Expression analysis at transcript level was done by RT-qPCR using Power
SYBER Green master mix (Applied Biosystems, Foster City, CA, USA) with 1 ng of cDNA and
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300 nM of each forward and reverse primer (S1 Table) in a final volume of 20 μL. Data were
analyzed by the ΔΔCt method [87]. Expression of target genes was normalized to the relative
expression of F. nucleatum-specific 16S rRNA [88]. Each experiment was performed in tripli-
cate and repeated 3 times.
Growth comparison of F. nucleatum WT and OsiaT in Columbia broth
F. nucleatum ATCC23726 WT and OsiaT were streaked out on supplemented Columbia blood
plates with streptomycin (1 mg/mL) and grown in an anaerobic chamber at 37˚C for 24 h.
Next day, colonies from the plates were gently scraped off using an inoculating loop and resus-
pended in supplemented Columbia broth. The OD600 of the suspension was checked and
adjusted to reach a final starting OD600 of 0.10 in fresh media. Media alone or inoculated with
F. nucleatum WT or OsiaT (150 μL /well) was transferred to a clear flat-bottom 96-well plate
(Cat. No. 655161; Greiner Bio-One) and sealed with a transparent seal (Cat No. 2978–2100;
USA Scientific, Ocala, FL, USA) to maintain anaerobic conditions. Growth was monitored by
recording the OD600 every 10 min, with 10 s linear shaking (amplitude 3 mm) followed by a
1-min pause at each time point, at 37˚C in a TECAN M200 plate reader (Morrisville, NC,
USA) for approximately 30 h.
Growth comparison of F. nucleatum WT and OsiaT in nutrient-limited
media
Experiments were conducted in a nutrient-limited media containing 1% (w/v) proteose pep-
tone #3, 0.5% (w/v) sodium chloride, and 16.8 mM HEPES under anaerobic conditions. F.
nucleatum ATCC23726 WT and OsiaT were first cultured overnight anaerobically in supple-
mented Columbia media. After approximately 16 h, in a clear flat-bottom 96-well plate (Cat.
No. 655161; Greiner Bio-One), each strain of F. nucleatum was inoculated in nutrient-limited
media (200 μL/well) containing different added carbohydrate sources as follows: (i) 30 mM
glucose, (ii) no added carbon source (low-carbohydrate), (iii) 30 mM Neu5Ac, (iv) 30 mM 3SL
(αNeu5Ac2-3βDGal1-4DGlc), and (v) 30 mM 3SL with 50 mU of A. ureafaciens sialidase.
Both strains were inoculated at starting OD600 of 0.1, and the plate was sealed with a transpar-
ent seal (Cat No. 2978–2100; USA Scientific) to maintain anaerobic conditions. Growth was
monitored by recording OD at 600 nm every 10 min, with 10 s linear shaking (amplitude 3
mm) followed by a 1-min pause at each time point at 37˚C in a TECAN M200 plate reader for
approximately 50 h.
Fluorometric assay for sialidase activity
All sialidase assays were performed in 96-well U-bottom black polypropylene plates (Eppen-
dorf). Plates were sealed with an optical clear film (Cat No. 2978–2100; USA Scientific) and
substrate hydrolysis was monitored by measuring fluorescence of 4-methylumbelliferone
(4MU) (excitation 365 nm, emission 440 nm) in a TECAN M200 plate reader every 2 min for
1–2 h at 37˚C. To test for potential sialidase activity produced by G. vaginalis and F. nucleatum,
overnight cultures were adjusted to an OD600 of 0.5 and 25 μL was mixed with an equal volume
of PBS in the plate, followed by the addition of 100 μL Dulbecco’s PBS containing 100 μM
4MU-Neu5Ac (4MU-sialic acid; Goldbio, St. Louis, MO, USA). To monitor sialidase activity
in mouse vaginal washes, 25 μL of vaginal wash was mixed with 50 μL PBS containing 100 μM
4MU-sialic acid. A standard curve of 4MU in PBS (0–67 μM) was included in parallel to calcu-
late the rate of 4MU-sialic acid hydrolysis by comparison to standards. Rate of 4MU-sialic acid
hydrolysis was used to compare sialidase activity in the mouse vaginal washes between differ-
ent time points or over a period of time. For in vitro experiments examining the effect of F.
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nucleatum on cultured mouse/human vaginal specimens or G. vaginalis, 50 μL of the final cul-
ture was mixed with 100 μL sodium acetate buffer (pH 5.5) containing 500 μM 4MU-sialic
acid. Similarly, for sialidase activity assays on (uncultured) human vaginal specimens, 50 μL of
resuspended swab eluates was transferred to the plate and mixed with 100 μL sodium acetate
buffer (pH 5.5) containing 500 μM 4MU-sialic acid. 4MU in sodium acetate buffer (0–
300 μM) was used as a standard in sialidase assays with vaginal swab eluates.
Foraging of sialic acids from bound sialoglycans in nutrient-limited media
by F. nucleatum in the presence or absence of exogenous sialidase
F. nucleatum WT and OsiaT were cultured in nutrient-limited media containing 3SL with or
without A. ureafaciens sialidase, as described above. At the end of the growth experiment,
96-well plates were centrifuged at 3,000 × g for 20 min at 4˚C to separate the media from bacte-
rial cells. Thereafter, spent supernatant from each growth condition (approximately 150 μL/
well) was transferred to 0.2-μm 96-well filter plates (Pall Corporation, Port Washington, New
York, USA) stacked onto a v-bottom 96-well collection plate (Eppendorf) and centrifuged at
3,000 × g for 15 min at 4˚C. Total and free sialic acids remaining in the filtered supernatants
were measured by DMB labeling as described earlier.
Mouse vendor information, housing conditions, and general handling
procedures
For experiments with F. nucleatum, female C57BL/6 mice (6–7 weeks old) were obtained from
Jackson Labs (Bar Harbor facility, MA, USA) and Envigo (202-A Indianapolis facility, IN,
USA). Mice were received between January 2016 and January 2017. For experiments testing
vaginal sialidase activity among different mouse vendors, female C57BL/6 mice were also
obtained from Charles River (NCI Grantee, Frederick facility, MD, USA) and Taconic. Once
received at Washington University, mice were housed in a barrier facility kept at 70 ± 2˚F,
with a 12:12 light/dark cycle, and using corncob bedding, PicoLab Rodent Diet 20, and nestlets
for enrichment changed at least once per week. During initial experiments, mice were housed
in standard (nonventilated) microisolator cages. Later, our animal facility changed to a new
housing system in which larger cages are docked in HEPA-filtered ventilation racks that pro-
vide airflow control. Mice were allowed to rest for approximately 1 week prior to the com-
mencement of procedures. Mice were estrogenized as indicated in figure legends by
intraperitoneal injection under isofluorane anesthesia with 0.5 mg β-estradiol 17-valerate
(E1631; Sigma-Aldrich) in 100 μL filter-sterilized sesame oil. Vaginal washes were collected
from isoflurane-anesthetized animals by gently inserting a pipette tip with 50 μL of sterile Dul-
becco’s PBS approximately 2–5 mm into the vagina and pipetting up and down.
Mouse model of vaginal colonization with F. nucleatum
Our spontaneous SmR isolate derived from ATCC23726, which we refer to simply as WT F.
nucleatum, was vital to these experiments because it allows us to distinguish inoculated F.
nucleatum from endogenous members of the microbiota for enumeration of CFUs. The OsiaT
strain described earlier was derived from this SmR WT strain. Mice were injected twice with β-
estradiol (see above) 3 days prior to and on the day of inoculation, with all animals receiving
the first dose approximately 1 week postarrival. To compare the vaginal colonization of F.
nucleatum WT versus OsiaT, a total of 80 mice (40 mice from each vendor) were used in 2
independent experiments, conducted approximately 1 year apart, with each individual experi-
ment including 20 mice from Envigo Labs and 20 from Jackson Labs. Ten mice per vendor
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were vaginally colonized with F. nucleatum WT and 10 with the F. nucleatum OsiaT. To pre-
pare the F. nucleatum inoculum, the overnight culture was adjusted to an OD600 of 4.0 in sup-
plemented Columbia broth and aliquoted in 1.5 mL Eppendorf tubes (25 μL/ tube) for each
individual mouse. Mice were vaginally inoculated with approximately 108 CFUs of WT or
OsiaT mutant in 20 μL supplemented Columbia broth using a separate aliquot of inoculum for
each mouse. In a separate experiment to compare persistence of sialidase activity, Envigo mice
were either mock treated by inoculating with supplemented Columbia broth (vehicle) or WT
F. nucleatum in supplemented Columbia broth (n = 10 per group). Vaginal washes were col-
lected every 2–3 days, and mice were considered sialidase-negative as of the first of 3 sequential
time points in which sialidase activity levels in vaginal washes were below 0.01 μM/min using
the 4MU-Sia assay.
Vaginal washes were collected one day before estradiol was first administered, after estro-
genization (on the day of inoculation), and then 3 times per week (on alternate days) until 38
dpi or 44 dpi (for mock versus F. nucleatum). Mice were considered “cleared” of F. nucleatum
when 2 consecutive washes were negative for F. nucleatum CFUs. Once cleared, mice did not
reacquire F. nucleatum, even if cohoused with colonized mice. Washes were collected from all
mice by flushing vaginas with 50 μL sterile PBS and rinsing into an additional 20 μL PBS in a
sterile 1.5-mL Eppendorf tube. All washes were collected (from 40 mice) within 1 h and cycled
into the anaerobic chamber for CFU enumeration. F. nucleatum titers were determined from
washes by preparing 10-fold serial dilutions in PBS and spotting 5 μL of each dilution in qua-
druplicate onto supplemented Columbia selection plates with 1 mg/mL streptomycin. After
anaerobic incubation at 37˚C, colonies were then enumerated and reported as recovered CFU
per mL of vaginal fluid. Sialidase activity was measured in freshly collected mouse vaginal
washes as described earlier. At appropriate experimental endpoints, mice were sacrificed by
cervical dislocation under isoflurane anesthesia or by using carbon dioxide at 10%–30% cham-
ber volume displacement per min using a SmartBox.
Ex vivo mouse vaginal community cultures
Mouse vaginal wash material remaining after sialidase assays and F. nucleatum CFU analysis
was pooled by cage (5 mice per cage) for each vendor or treatment condition. A small portion
(5 μL) of each pooled vaginal wash sample was used as inoculum to culture the vaginal bacte-
rial communities in supplemented Columbia broth under anaerobic conditions. We refer to
these vaginal communities as “microbiota pools.” Each microbiota pool represents either
uncultured pooled vaginal wash or cultured bacterial community from pooled vaginal wash of
mice cohoused in the same cage. The cultured communities (first passage) were frozen with
20% glycerol after overnight growth. Remaining pooled vaginal washes were stored at −20˚C
for later microbiome studies (see below). See also S1 Schematic.
F. nucleatum’s influence on sialidase activity in mouse vaginal communities
Experiments were done with microbial communities cultured using pooled vaginal wash spec-
imens (referred to as “microbiota pools”) collected from both Envigo and Jackson mice after
estrogenization but before inoculation with F. nucleatum. These experiments were done in
Columbia broth, a culture medium that contains sialoglycans from animal ingredients, but
these remain inaccessible to F. nucleatum because of lack of sialidase activity. Cultured mouse
vaginal communities (first passage) frozen in Columbia media were streaked out on Columbia
blood plates and grown in an anaerobic chamber at 37˚C (second passage). After 2 days,
Columbia blood plates were gently scraped using an inoculating loop, and bacteria were resus-
pended in supplemented Columbia broth. The OD600 of the suspension was checked and
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adjusted to 0.5 for the vaginal communities and 1.0 for both F. nucleatum strains. Experiments
were done in v-bottom, 96-well, sterile, deep-well (2-mL) plates (Eppendorf). F. nucleatum
WT orOsiaT was added in equal amounts to 700 μL (total volume of media per well) of
Columbia broth at a starting OD600 of either 0.10 or 0.025, followed by addition of vaginal
communities at starting OD600 0.05. Appropriate controls such as uninoculated Columbia
broth, Columbia broth inoculated with F. nucleatum alone at a starting OD600 of 0.10, and
Columbia broth inoculated with each individual vaginal microbial community alone were
included in each experiment. After the addition of aluminum foil seals (Product ID:
BK538619; Beckman Coulter Life Sciences, Indianapolis, IN, USA), plates were incubated O/N
(approximately 16 h) at 37˚C in the anaerobic chamber. After O/N growth (third passage of
mouse communities), sialidase activity was checked in each well using the fluorometric siali-
dase assay as described earlier in the Methods. Also, growth of F. nucleatum WT and OsiaT
with the microbiota pools was determined at this point by preparing 10-fold serial dilutions of
the O/N cultures in PBS and spotting 5 μL of each dilution onto Columbia selection plates con-
taining 1 mg/mL streptomycin and 5 mg/L of crystal violet. Microbiota pools cultured without
F. nucleatum did not show any growth on these plates (crystal violet selects against gram-posi-
tive bacteria), thus allowing selective enumeration of F. nucleatum in the cocultures. See also
S1 Schematic.
DNA extraction and community profiling of mouse vaginal washes
For microbiome analysis by 16S sequencing, pooled vaginal washes (uncultured microbiotas)
from 8 different cages (4 for each vendor, 1 specimen per cage) were centrifuged at 16,000 × g
for 5 min, the supernatant was removed, and the pellet was used for DNA extraction. For cul-
tured vaginal communities (4 for each vendor, 1 specimen per cage), communities frozen in
supplemented Columbia broth were streaked out on supplemented Columbia blood plates and
grown overnight at 37˚C in an anaerobic chamber (second passage). Colonies from plates
were gently scraped off using a cell scraper and resuspended in supplemented Columbia broth.
For DNA extraction, bacterial cells from these communities were separated from the superna-
tant by centrifugation at 16,000 × g for 5 min. DNA was extracted using the Wizard Genomic
DNA Purification kit from Promega (Cat. No. A1120; Madison, WI, USA) following supplier
instructions. See also S1 Schematic.
Mouse vaginal community analysis by V1–V2 sequencing of the 16S rRNA
gene
For the mouse microbiome experiments, we decided to use the 16S V1–V2 regions after doing
a preliminary experiment using the 16S V4 region, which was unable to identify and distin-
guish members of the Lactobacillales down to the species level (for example, E. faecalis and E.
casseliflavus/gallinarum). We amplified the V1–V2 region of the 16S ribosomal subunit with
the universal 27F and 338R primers [4]. Both the primers contained a common adaptor
sequence and the forward primer also contained a barcode sequence for multiplexing. The
primers were as follows: 338R-50-AGACGTGTGCTCTTCCGATCTCATGCTGCCTCCCG
TAGGAGT-30 and 27F-50-ACGACGCTCTTCCGATCTNNNNNNNNCTAGAGTTTGAT
CCTGGCTCAG-30, with the bolded sequences denoting the universal primers and 8-bp bar-
code being denoted by 8 Ns. After the V1–V2 region was amplified using the 27F and 338R
primer pair, the PCR product was treated with Exo-SAP-IT to remove primers. A second PCR
was performed to add unique indexes for further multiplexing. The subsequent amplicons
were quantified and pooled. The pool was run on a 0.8% agarose gel, excised, and extracted.
Agencourt AMPure XP beads (Beckman Coulter Life Sciences) were used for further size
PLOS BIOLOGY Fusobacterium and the vaginal microbiota
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000788 August 25, 2020 23 / 36
selection and purification. The 2 × 150 paired-end sequencing was completed using the Illu-
mina MiniSeq platform (San Diego, CA, USA) through the Center for Genome Science at
Washington University School of Medicine. Reads were trimmed for adaptor sequences using
ea-utils fastq-mcf version 1.04.676 and de-multiplexed based on the unique barcode and index
identifiers. USEARCH [89] version 10.0.240 was used for the following USEARCH com-
mands: (i) reads were merged using the fastq_mergepairs command and (ii) quality filtered
with a maximum expected error of 1 and a minimum sequence length of 100 using the fas-
tq_filter command, (iii) merged reads were then dereplicated using the fastx_uniques com-
mand, and (iv) OTUs were clustered using the cluster_otus command (97% OTU clustering
using UPARSE-OTU algorithm) or unoise3 command (UNOISE algorithm also performs
denoising of amplicon reads). As part of the cluster_otus and unoise3 commands, chimeric
sequences were filtered out and discarded, and a minimum abundance of 2 reads per OTU
was applied. OTUs were assigned taxonomic predictions using the RDP 16S database (version
16) with a confidence threshold of 0.7. For normalization, samples were rarified to 1,000 reads
per sample. To quantify relative abundance of each OTU in a given sample, OTU reads were
log transformed using the following equation: log([reads + 1]/total reads). All OTUs at>1%
relative abundance in at least one sample were included in analysis. Data were clustered using
hierarchical Euclidean clustering in the R project for statistical computing. As in other micro-
biome studies, sampling methods and primer choice could bias the types of microbes recov-
ered and detected. These limitations may apply to the vaginal microbiome in mice as well as in
women.
Mouse model of vaginal inoculation with E. coli
Female C57BL/6 mice, 5–7 weeks old, were obtained from Envigo (202-A Indianapolis facil-
ity). At 48 and 24 h prior to infection, mice underwent intraperitoneal injections of 0.5 mg β-
estradiol 17-valerate (Sigma-Aldrich) in 100 μl filter-sterilized sesame oil (Thermo Fisher Sci-
entific) to synchronize the mice in estrus. Mice were infected with model uropathogenic E. coli
strains (UTI89 and CFT073 [90,91]) or mutant derivatives thereof. Strains were cultured stati-
cally in lysogeny broth (LB) at 37˚C for 2 consecutive overnight passages. At the time of infec-
tion, 104 CFUs of each E. coli strain were inoculated into the vaginas in 20-μl volumes of PBS.
To monitor infection and sialidase status, vaginal washes were collected as described above,
serially diluted, and plated on MacConkey agar (titers of these uropathogenic strains went up
to approximately 108 CFUs by 24 hpi) [59]. Sialidase activity was measured in freshly collected
mouse vaginal washes as described above.
Study design for human subject research
To test our hypothesis that sialidase activity would significantly increase in living communi-
ties cultured with F. nucleatum compared with identical communities exposed only to vehi-
cle, our experimental design required that some detectable level of sialidase be present
within the microbiome of tested communities. Sialidase activity was measured in 51 avail-
able (standard aerobic) swab specimens, of which approximately 60% were sialidase-posi-
tive. For the power calculation, our primary outcome was sialidase activity after overnight
culture of cryogenically preserved living communities. The exact Agresti–Coull method was
used to estimate the sample size needed for the ex vivo studies. To achieve 80%–90% power
(alpha = 0.05) to detect sialidase altered in 80% of samples (versus the theoretical random
distribution of sialidase levels, which would give 50% of samples with higher sialidase activ-
ity in the treatment group), we calculated that we would need 22–28 independent commu-
nities. Our experimental design in 96-well plates using different inocula of F. nucleatum
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allowed us to evaluate a total of 21 communities in 2 independent experiments (11 commu-
nities in the first experiment and 10 communities + 1 duplicate community in the second).
There was good agreement between the data for the community that was evaluated in dupli-
cate. Combined data from both experiments are shown (each data point represents a com-
munity from 1 individual). Further measurements of G. vaginalis levels (by qPCR and
proportions within the postculture communities) were performed as described in the Meth-
ods below.
Collection and processing of human vaginal swabs
Midvaginal swabs were collected during speculum exam by a clinician, immediately sub-
merged into prereduced Cary Blair media using Starswab Anaerobic Transport System S120D
(Starplex Scientific, Ontario, Canada), and transported to the laboratory for same-day process-
ing. Once transported anaerobically to the lab, vaginal swabs were cycled into the anaerobic
chamber immediately. Swabs were eluted in 2× NYCIII media without glucose, and “fresh-fro-
zen” (i.e., “0 passage,” without growth or amplification of any kind) in the presence of sterile
glycerol (20% final). In parallel with clinical specimens returning to the lab in anaerobic trans-
port devices, control swabs exposed to the air in clinic exam rooms were also transported
anaerobically to the lab and processed in parallel with clinical specimens. Standard (aerobic)
double-headed rayon swabs S09D (Starplex Scientific) collected at the same visit were eluted in
1 mL of pH 5.5 sodium acetate buffer, and sialidase activity was measured as described earlier
in the Methods. For coculture experiments with F. nucleatum, we selected anaerobic fresh-fro-
zen vaginal microbial communities from women whose aerobic vaginal swab eluates had
detectable sialidase activity (S7 Fig). Fresh-frozen communities from 21 sialidase-positive
women were used. See also S2 Schematic.
Ex vivo studies of human vaginal communities
F. nucleatum ATCC23726 WT was streaked out on supplemented Columbia blood plates and
grown in an anaerobic chamber at 37˚C for 24 h. The next day, F. nucleatum colonies from
plates were gently scraped off using an inoculating loop and resuspended in supplemented
Columbia broth. The OD600 of the suspension of F. nucleatum was adjusted to 1.0. Then, F.
nucleatum inocula were prepared by 2-fold serial dilution in supplemented Columbia media.
Fresh-frozen (passage 0) human vaginal communities (N = 21) were thawed on ice and diluted
4-fold in 1× NYCIII with no added glucose (low-carbohydrate medium). Experiments were
done in v-bottom, 96-well, sterile, deep-well (2-mL) plates (Cat. No. 951033502; Eppendorf).
F. nucleatum was inoculated at a starting OD600 of 0.10, followed by addition of 116 μL of the
diluted fresh-frozen community in a total of 700 μL media (supplemented Columbia broth)
per well. Mock vaginal communities were included as controls in each experiment; these mock
communities were originally prepared from blank swabs that were eluted and stored using the
same media and reagents, in parallel with swabs returning from the clinic. The plates were
sealed with a sealing aluminum foil (Product ID: BK538619; Beckman Coulter) and incubated
overnight (17 h) at 37˚C in the anaerobic chamber. After overnight growth (first passage of
human communities), 50 μL of culture from each condition was transferred to round-bottom
black plates, and sialidase activity was measured in each well using the fluorometric sialidase
assay as described earlier in the Methods. The 96-well plates with the remaining cultures were
centrifuged at 3,200 × g for 20 min at 4˚C, and supernatants were removed carefully without
touching the bacterial cell pellets at the center of the well and stored at −80˚C for DNA extrac-
tion and PCR as described below. See also S2 Schematic.
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DNA extraction from ex vivo-cultivated human vaginal communities
DNA was extracted from bacterial cell pellets, saved from the F. nucleatum human vaginal
communities coculture experiments described above, by bead beating followed by phenol
chloroform extraction. Briefly, a 96-well (deep-well, v-bottom) plate with bacterial pellets was
thawed, and cells were resuspended in 250 μL of buffer containing 200 mM Tris-HCl (pH 8.0),
200 mM NaCl, and 20 mM EDTA. This suspension was transferred to sterile 2-mL tubes (Axy-
gen, Corning, NY, USA) containing approximately 250 μL silica beads and 105 μL 20% SDS,
followed by addition of 250 μL phenol/chloroform/isoamyl alcohol saturated with 10 mM Tris
(pH 8.0). After bead beating for 3 min, tubes were centrifuged at 3,200 × g for 4 min, and the
crude DNA was transferred to clean up columns (Qiagen). Concentration of the purified DNA
was determined using Quant-iT BR dsDNA Assay Kit (Thermo Fisher Scientific). Before PCR,
DNA was normalized to 2.5 ng/μL for each condition.
16S profiling of ex vivo-cultivated human vaginal communities
16S rRNA PCR was performed in triplicate for each template using Platinum Taq DNA Poly-
merase, High Fidelity (Thermo Fisher Scientific) using barcoded V4-specific primers as previ-
ously described [92]. No-template controls were additionally run with every barcoded primer
to ensure that reactions were free from contamination. Replicate PCR reactions were com-
bined and then quantitated using Qubit dsDNA Broad Range Assay reagents (Invitrogen, Wal-
tham, MA, USA). Quantitated DNA V4 16S reactions were then pooled into a single library in
an equimolar ratio using the epMotion 5075 TMX (Eppendorf, Hamburg Germany). V4 16S
rRNA amplicon libraries were then sequenced on an Illumina MiSeq instrument using 2 × 250
base pair chemistry. Amplicon sequence variants were generated from the de-multiplexed data
using the large-data–adapted pipeline for DADA2 version 1.10.1 in R (https://benjjneb.github.
io/dada2/bigdata.html) [93]. The forward and reverse reads were trimmed to 230 base pairs
and 160 base pairs, respectively, based on the average quality profile of forward and reverse
reads. Sequences with more than 2 likely erroneous bases or any ambiguous bases were then
filtered out. Sequencing errors were learned and amplicons were then de-replicated and parti-
tioned into amplicon sequence variants as described [93]. Forward and reverse reads were sub-
sequently merged, and chimeras were removed. Amplicon sequence variant sequences were
assigned taxonomy from kingdom to species using the DADA2 inbuilt function for the naïve
Bayesian Classifier [94] with a custom database [95] and a minimum bootstrap support of
80%. For data shown in Fig 7C, we excluded the reads for F. nucleatum ATCC23726 (added
exogenously) when determining the total reads to calculate relative levels of G. vaginalis. Some
samples were excluded from the final analysis that had insufficient numbers of reads (0) map-
ping to G. vaginalis in either of the conditions tested.
Cloning the tuf gene from G. vaginalis
The primer pair Gvag_tuf_AS3/Gvag_tuf_S4 was used to amplify a 149-bp fragment from the
tuf gene (GI:311114364) of G. vaginalis strain JCP8481B. The PCR product was purified using
the Nucleospin Gel and PCR Clean-Up Kit (Clontech, Takara Bio, Mountain View, CA, USA)
and cloned into the Zero Blunt TOPO vector (Invitrogen) according to the manufacturer’s
instructions.
Quantification of G. vaginalis by tuf qPCR
DNA was extracted from human vaginal communities cultured with/without F. nucleatum as
described above. qPCR was performed using PowerUp SYBR Green Master Mix (Applied
PLOS BIOLOGY Fusobacterium and the vaginal microbiota
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000788 August 25, 2020 26 / 36
Biosystems) with 5 ng of DNA and 250 nM of tuf forward and reverse (Gvag_tuf_AS3/Gvag_-
tuf_S4) primers in a final volume of 20 μL. Plasmid containing a 149-bp fragment of tuf gene
from G. vaginalis was employed to generate a standard curve for quantitation. Three replicates
were included for each experimental condition, including the no-template control, DNA
derived from media-only controls, and blank swab controls. The average CT values from the
triplicate reactions were used to calculate the tuf copy numbers using the linear equation
derived from the standard curve. No-template controls, media-only controls, and blank swab
controls fell outside the standard curve (less than 800 copies). G. vaginalis levels are expressed
as tuf gene copies per community.
Coculture experiments with Fusobacterium and G. vaginalis
Coculture experiments were done in v-bottom, 96-well, sterile, deep-well (2 mL) plates
(Eppendorf). F. nucleatum ATCC23726 (WT orOsiaT) and G. vaginalis JCP8151B (SmR) were
streaked out on supplemented Columbia blood plates and NYCIII plates with streptomycin (1
mg/mL), respectively, and grown in anaerobic chamber at 37˚C for 24 h. The next day, colo-
nies from the plates were gently scraped off using an inoculating loop and resuspended in sup-
plemented Columbia broth. For experiments measuring sialidase activity in the coculture, the
OD600 of the suspension was checked and adjusted to 0.05 (1.20 × 108 CFU/mL) for G. vagina-
lis and 0.1 for F. nucleatum (WT, 1.80 × 108 CFU/mL; OsiaT, 2.20 × 108 CFU/mL). A series of
inocula were prepared for each strain by 2-fold serial dilution. For coculture, prepared inocula
for both F. nucleatum and G. vaginalis were diluted 10-fold in a total of 700 μL of supple-
mented Columbia broth per well. The plate was sealed with a sealing aluminum foil (Beckman
Coulter) and incubated overnight (17 h) at 37˚C in the anaerobic chamber. After overnight
growth, sialidase activity was measured in each well using the fluorometric sialidase assay as
described earlier. G. vaginalis titers were determined after overnight growth for a subset of the
wells (Fig 8A, G. vaginalis inoculum 2.28 × 105 CFU/mL), with and without WT F. nucleatum
(at the indicated inoculum OD), by preparing 10-fold serial dilutions in PBS (in the anaerobic
chamber) and spotting 5 μL of each dilution in quadruplicate onto NYCIII plates containing 1
mg/ml streptomycin, 10 μg/ml colistin, and 10 μg/ml nalidixic acid (colistin and nalidixic acid
select against gram-negative bacteria and allow the specific enumeration of G. vaginalis in this
assay). In separate experiments, G. vaginalis was cocultured with or without F. nucleatum
(inoculum OD600 0.10) at varying inocula, with the highest G. vaginalis inoculum tested having
OD600 1.3 (1 × 109 CFU/mL), and titers were determined after overnight growth as described
above.
Experiments with F. nucleatum cell-free supernatants
Preparation of cell-free supernatants: F. nucleatum WT inoculum was prepared as described
earlier. A 10 mL culture was started in supplemented Columbia broth at OD600 0.01 (2.8 × 107
CFU/mL of F. nucleatum). After overnight growth (approximately 18 hr), bacterial cells were
pelleted by centrifugation at 12,000 × g for 10 min, and the supernatant was transferred to a
new tube. A second centrifugation step was included (12,000 × g for 10 min) to remove any
remaining bacterial cells, and the supernatant was subsequently filtered through a 0.22-μm
membrane to obtain cell-free spent media. These filtered supernatants were spread plated on
supplemented Columbia agar and incubated at 37˚C for 2 days (no live bacteria were recov-
ered, LOD = 10 CFU/ml). The cell-free supernatant was cycled in the anaerobic chamber at
least 4 h before inoculation with G. vaginalis.
Growth of G. vaginalis in cell-free supernatants from F. nucleatum: Experiments were done
in v-bottom, 96-well, sterile, deep-well (2-mL) plates (Cat. No. 951033502; Eppendorf).
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Inocula of G. vaginalis (3.0 × 105 CFU/mL) and F. nucleatum (OD600 0.1, 2.5 × 108 CFU/mL)
were prepared from colonies on solid-media plates (after 24 h growth) as described above. The
inoculum was diluted 10-fold in supplemented Columbia broth with or without cell-free
supernatants in a final volume of 700 μL medium per well. The plate was sealed and incubated
overnight (approximately 18 h) at 37˚C in the anaerobic chamber. After overnight growth,
CFUs were enumerated by 10-fold serial dilutions in PBS as described above.
Statistical analysis
R project for statistical computing was used for hierarchical clustering of microbiome data.
GraphPad Prism 7.0 software was used for all statistical analyses presented. The statistical tests
used to analyze each set of data and the number of replicates or independent experiments are
indicated in the figure legends. For animal experiments, the figures with titers or sialidase
activity show individual data, with each data point representing a value from a different animal
with a line at the median. For experiments with human vaginal communities, each data point
represents a vaginal community from an individual woman. For nonparametric analyses, dif-
ferences between the experimental groups were analyzed with a two-tailed unpaired Mann–
Whitney U test, or, when making multiple comparisons, we used Dunn’s test. In the experi-
ments in which data sets are paired, differences were analyzed using Wilcoxon matched-pairs
sign rank test. Survival analysis was done using the Gehan–Breslow–Wilcoxon test.
Supporting information
S1 Fig. A subgroup of F. nucleatum strains encode putative sialate lyase (NanA) homologs.
(A) Heat map showing percent identity of NanA homologs in sequenced F. nucleatum strains
to the amino acid sequence of sialic acid lyase of E. coli MG1655. Homologs showed high simi-
larity to amino acid sequence of lyase from F. nucleatum ATCC23726. ATCC, American Type
Culture Collection; NanA, N-acetylneuraminate lyase.
(TIFF)
S2 Fig. Growth of F. nucleatum in supplemented Columbia media. (A) F. nucleatum WT
and OsiaT show similar growth when cultured anaerobically under these culture conditions.
Data shown are representative of 3 independent experiments. siaT, predicted sialic acid trans-
porter; WT, wild type.
(TIFF)
S3 Fig. C57BL/6 mice from Envigo have endogenous vaginal sialidase activity. (A) Sialidase
activity in vaginal washes of mice (not estrogenized) from different vendors measured using
the fluorogenic 4MU-Neu5Ac substrate. N = 10 mice/vendor. (B) Vaginal sialidase activity is
elevated at 72 h postestrogenization in mice from Envigo. No sialidase activity was detected in
vaginal washes of mice from Jackson. N = 40 mice/vendor. Wilcoxon paired-sign rank test was
used for pairwise comparison. ��P< 0.01. (C) Sialidase activity in microbiota pools from
Envigo and Jackson mice, collected after estrogenization. Each “microbiota pool” consists of a
cultured vaginal community from pooled vaginal washes of 4–5 cohoused mice. For A, B, and
C, data shown are combined from 2 independent biological replicates. (D) Heat map shows
relative abundance of bacterial taxa identified by 16S rRNA V1–V2 sequencing in vaginal spec-
imens of Envigo and Jackson mice collected before and after estrogenization. Microbiome
analysis was done on uncultured and cultured vaginal washes pooled from 5 mice housed in
the same cage. Each column represents 1 pool = 1 cage = 5 mice. Total = 4 microbiota pools
per vendor per condition. OTUs were clustered using UPARSE-OTU algorithm, and taxo-
nomic predictions were assigned using the RDP 16S rRNA database. (E) For identification of
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sialidase-positive bacteria in Envigo mice, frozen microbiota pools were streaked on supple-
mented Columbia blood plates anaerobically incubating for 24 h at 37˚C. Single colonies were
gently picked from these plates and cultured overnight. (F) Sialidase-positive cultures were
identified using 4MU-Sia assay. Strains were identified by amplification and sequencing of 16S
gene. Percent identity to the recovered blast hits is given in parentheses. The underlying
numerical data for this figure can be found in S1 Data and S2 Data. Neu5Ac, N-acetylneurami-
nic acid; OTU, Operational Taxonomic Unit; RDP, Ribosomal Database Project; 4MU,
4-methylumbelliferone.
(TIFF)
S4 Fig. Fusobacterium vaginal colonization and sialic acid foraging in C57BL/6 mice from
Envigo inoculated with F. nucleatum WT and OsiaT. (A) F. nucleatum titers in vaginal wash
collected at the indicated time points postinoculation. Data are combined from 2 independent
experiments. Each experiment had 10 mice per group. �P< 0.05, ��P< 0.01, Mann–Whitney.
(B) Free and total sialic acid (Neu5Ac) concentrations in vaginal wash at 8 dpi. Total N = 18.
The underlying numerical data for this figure can be found in S1 Data. dpi, days postinocula-
tion; N-acetylneuraminic acid; siaT, predicted sialic acid transporter; WT, wild type.
(TIFF)
S5 Fig. F. nucleatum WT and OsiaT vaginal colonization in C57BL/6 mice from Jackson.
(A) F. nucleatum titers in vaginal wash collected at the indicated time points postinoculation.
(B) Comparison of vaginal colonization with the WT versus OsiaT. Number of mice colonized
in percent (y axis) was monitored on day 1 and every 2 days thereafter for 38 days (x axis). For
Kaplan–Meier analysis, mice were considered cleared when no CFUs were detected in undi-
luted wash at 2 consecutive time points. Data are combined from 2 independent experiments.
Each experiment had 10 mice per group. Statistical significance assessed by the Gehan–Bre-
slow–Wilcoxon test revealed no significant difference in colonization by WT versus OsiaT in
mice from Jackson. The underlying numerical data for this figure can be found in S1 Data.
CFU, colony-forming unit; siaT, predicted sialic acid transporter; WT, wild type.
(TIFF)
S6 Fig. Vaginal sialidase activity in E. coli- and F. nucleatum-inoculated mice. (A–B) Siali-
dase activity in vaginal washes from individual animals purchased from Envigo, estrogenized,
and inoculated with E. coli (A) or F. nucleatum (B) from 1 to 8 dpi. The underlying numerical
data for this figure can be found in S1 Data. dpi, days postinoculation.
(TIFF)
S7 Fig. Analysis of sialidase activity in vaginal swab eluates for selection of human vaginal
communities. (A) Graph shows relative sialidase activity in vaginal swabs that were trans-
ported aerobically from clinic to the lab. Sialidase activity was measured in swab eluates
(N = 58) using a 4MU-Sia assay. Samples with a relative sialidase activity >1.0 were considered
to be sialidase-positive. Red = sialidase-positive specimens, green = blank swab controls,
blue = buffer control. The underlying numerical data for this figure can be found in S1 Data.
4MU, 4-methylumbelliferone.
(TIFF)
S8 Fig. Sialidase activity amplification in G. vaginalis cocultured with F. nucleatum. (A)
Heat map shows relative sialidase activity in G. vaginalis (inoculum OD600 0.0–0.05) cultured
overnight with F. nucleatum OsiaT (inoculum OD600 0.0–0.1) in supplemented Columbia
media. Data shown are representative of 2 independent experiments. OD, optical density;
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siaT, predicted sialic acid transporter.
(TIFF)
S1 Schematic. Mouse vaginal microbial communities—collection and amplification. Step 1:
collection of mouse vaginal washes. Publication of this animal image was approved by IACUC.
Washes were pooled from mice cohoused in the same cage. A portion of vaginal wash pools
was cultured in Columbia broth (referred to as “microbiota pools”) to amplify the vaginal bac-
teria and frozen for subsequent use. Remaining pooled material was stored at −20˚C. Step 2:
on the day of the experiment, frozen microbiota pools were used to recover mouse vaginal bac-
teria by streaking out on supplemented Columbia blood plates in anaerobic chamber and incu-
bating for 24 h at 37˚C. Colonies from these plates were resuspended in liquid media either (a)
for DNA extraction or (b) for coculture experiments with F. nucleatum. IACUC, Institutional
Animal Care and Use Committee.
(TIFF)
S2 Schematic. Human vaginal microbial communities—collection and amplification. Step
1: anaerobic and aerobic vaginal swabs were collected on the same day from each participant.
Aerobic swabs were eluted in sodium acetate buffer (pH 5.5), and sialidase activity was
checked in the swab eluates using fluorogenic 4MU-Neu5Ac substrate. Anaerobic swabs were
eluted in 2× NYCIII media (in an anaerobic chamber) and the communities were “fresh fro-
zen,” without any amplification/overnight culture, by mixing with cryoprotectant and storing
at −80˚C. Step 2: on the day of the experiment, fresh-frozen anaerobic vaginal communities,
from women who had detectable sialidase activity in their aerobic swab eluates, were thawed at
4˚C and diluted 4-fold in NYCIII media (in an anaerobic chamber). The diluted communities
were used for coculture experiments with F. nucleatum. Neu5Ac, N-acetylneuraminic acid;
4MU, 4-methylumbelliferone.
(TIFF)
S1 Table. Key bacterial strains, plasmids, and primers.
(PDF)
S2 Table. Genetic organization of the putative sialic acid catabolic gene cluster in F. nucle-
atum strain ATCC 23726. ATCC, American Type Culture Collection.
(PDF)
S1 Data. Contains underlying numerical data for the graphs in Figs 1–8 and S3–S7 Figs.
(XLSX)
S2 Data. Contains underlying data for S3D Fig.
(XLSX)
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